TGGI is a very different story. in 2022 they increased the A/S from 12 billion to 99 billion and increased the O/S from 8 billion to 22 billion. When they then tried to do the R/S in January 2023, FINRA said the request was deficient.
99 billion A/S. That's really kind of absurd. And issuing 14 billion new shares in one year? Lucy, you got some 'splainin' to do. FINRA didn't buy their explanation.
Here's another Chinese entity that bought a shell and diluted it into the dust -- and we can all find a dozen more:
So let's be realistic about shells and reverse mergers, and not just Chinese shells but the OTC in general. There are criminals who buy OTC shells and dilute them into the dust. The hope here OBVIOUSLY is that JGH is not one of these criminals. Nobody knows the truth yet so don't believe anyone who pretends to know the truth, pro or con.
In the OTC we've all made money on longer shots and lost money on surer things. I'm in, and not because some criminal "chartist" is pumping it. We all know that TA doesn't work on pinksheet stocks, so that's an easy tell -- the fool who's gushing ""the charts are telling me...." would also read your tea leaves if you pay him and sell you a bridge if you're interested.